Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 19,884 shares at $39.31 ($782K) on 2018-12-04, disclosed to the SEC on 2018-12-04.
Open-market sale of $782k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.31 | 9,884 | $389K | 49.7% |
| 2 | $39.31 | 9,884 | $389K | 49.7% |
| 3 | $40.00 | 116 | $5K | 0.6% |
| Total | $39.31 avg | 19,884 | $782K | 100% |
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |